Ulase et al., 2020 - Google Patents
Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus ConferenceUlase et al., 2020
View PDF- Document ID
- 16232612634891505772
- Author
- Ulase D
- Heckl S
- Behrens H
- Krüger S
- Röcken C
- Publication year
- Publication venue
- Histopathology
External Links
Snippet
Aims In this study, we aimed to independently evaluate the utility and prognostic value of tumour budding (TB) according to the International Tumour Budding Consensus Conference (ITBCC) criteria in a large and a well‐characterised European gastric cancer (GC) cohort …
- 206010017758 Gastric cancer 0 title abstract description 52
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ulase et al. | Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference | |
| Kawaguchi et al. | Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy | |
| Rieger et al. | Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer | |
| Karram et al. | Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings | |
| Hodgson et al. | p53 immunohistochemistry in high‐grade urothelial carcinoma of the bladder is prognostically significant | |
| Lai et al. | Tumour budding is a reproducible index for risk stratification of patients with S tage II colon cancer | |
| Teramoto et al. | Tumor budding as a useful prognostic marker in T1‐stage squamous cell carcinoma of the esophagus | |
| Norwood et al. | Lymph node retrieval in colorectal cancer resection specimens: national standards are achievable, and low numbers are associated with reduced survival | |
| Green et al. | KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach | |
| Tanaka et al. | Tropomyosin-related receptor kinase B at the invasive front and tumour cell dedifferentiation in gastric cancer | |
| Snoeren et al. | Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer | |
| Kaushik et al. | Long‐term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder | |
| Peng et al. | Update on immunohistochemical analysis in breast lesions | |
| Al‐Sohaily et al. | Loss of special AT‐rich sequence‐binding protein 1 (SATB 1) predicts poor survival in patients with colorectal cancer | |
| Godfrey et al. | Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion | |
| Tsang et al. | αB‐crystallin is a useful marker for triple negative and basal breast cancers | |
| Margulis et al. | Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system | |
| Tanaka et al. | Tumor budding in intrahepatic cholangiocarcinoma: a predictor of postsurgery outcomes | |
| Bonetti et al. | Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery? | |
| Yoon et al. | Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer | |
| Ejlertsen et al. | Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancer | |
| Hollemans et al. | Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy | |
| Nordholm‐Carstensen et al. | Mismatch repair status and synchronous metastases in colorectal cancer: a nationwide cohort study | |
| Schiavina et al. | Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and G leason score | |
| Lotan et al. | Modelling cost‐effectiveness of a biomarker‐based approach to neoadjuvant chemotherapy for muscle‐invasive bladder cancer |